EPIX logo

ESSA Pharma (EPIX) EBITDA

Annual EBITDA

-$28.45 M
-$2.00 M-7.55%

September 30, 2024

Summary

Performance

1-Year Change

-7.55%

3-Year Change

+22.49%

5-Year Change

-134.83%

15-Year Change

-701.04%

EPIX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

44.65%
EPIX annual EBITDA is higher than 44.65% of companies in Healthcare sector

High & Low

All-time High

-$1.71 M

3-Year Low

-$36.71 M

Earnings dates

Last Annual Earnings Report Date

Sep 30, 2024
EPIX previous annual earnings announcement was published on Sep 30, 2024

Next Annual Earnings Report Date

N/A
EPIX next annual earnings announcement has not yet been scheduled

OtherEPIXprofitabilitymetrics:

Annual Revenue

-
EPIX annual revenue value is unknown

Annual Net Income

-$28.54 M
EPIX annual net profit is -$28.54 million

Annual EBIT

-$28.54 M
EPIX annual earnings before interest & taxes is -$28.54 million

Annual EPS

-$0.64
EPIX annual earnings per share is -$0.64

Quarterly EBITDA

-$6.33 M
+$878.70 K+12.19%

September 30, 2024

Summary

Performance

3-Month Change

+12.19%

1-Year Change

+12.19%

3-Year Change

+25.73%

5-Year Change

-36.23%

EPIX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

43.16%
EPIX quarterly EBITDA is higher than 43.16% of companies in Healthcare sector

High & Low

All-time High

$3.97 M
EPIX quarterly EBITDA is currently -259.68% below its historical high of $3.97 million

3-Year Low

-$10.76 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
EPIX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 13, 2025
EPIX next earnings announcement is scheduled for Feb 13, 2025

OtherEPIXprofitabilitymetrics:

Quarterly Revenue

-
EPIX quarterly revenue value is unknown

Quarterly Net Income

-$6.36 M
EPIX quarterly net profit is -$6.36 million

Quarterly EBIT

-$6.36 M
EPIX quarterly earnings before interest & taxes is -$6.36 million

Quarterly EPS

-$0.14
EPIX quarterly earnings per share is -$0.14

TTM EBITDA

-$28.45 M
-$879.30 K-3.19%

September 30, 2024

Summary

Performance

3-Month Change

-3.19%

1-Year Change

-3.19%

3-Year Change

+22.49%

5-Year Change

-99.92%

EPIX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

43.32%
EPIX TTM EBITDA is higher than 43.32% of companies in Healthcare sector

High & Low

All-time High

-$225.60 K

3-Year Low

-$39.24 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
EPIX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 13, 2025
EPIX next earnings announcement is scheduled for Feb 13, 2025

OtherEPIXprofitabilitymetrics:

TTM Revenue

-
EPIX TTM revenue value is unknown

TTM Net Income

-$28.54 M
EPIX TTM net profit is -$28.54 million

TTM EBIT

-$28.54 M
EPIX TTM earnings before interest & taxes is -$28.54 million

TTM EPS

-$0.64
EPIX TTM earnings per share is -$0.64

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$28.45 M
EPIX annual EBITDA is -$28.45 million

Annual Net Income

-$28.54 M
EPIX annual net profit is -$28.54 million

Annual Interest Expense

$0.00
EPIX annual interest expense is $0.00

Annual Income Tax

$0.00
EPIX annual income tax is $0.00

Annual D&A

$90.70 K
EPIX annual depreciation & amortization is $90.70 thousand

EPIX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-7.5%+12.2%-3.2%
3 y3 years+22.5%+25.7%+22.5%
5 y5 years-134.8%-36.2%-99.9%

EPIX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-7.5%+22.5%-16.1%+41.1%-10.8%+27.5%
5 y5-year-134.8%+22.5%-43.2%+51.0%-99.9%+27.5%
alltimeall time-1561.0%+22.5%-259.7%+51.0%<-9999.0%+27.5%

ESSA Pharma EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-$28.45 M(+7.5%)
-$6.33 M(-12.2%)
-$28.45 M(+3.2%)
Jun 2024
-
-$7.21 M(-19.6%)
-$27.57 M(-0.2%)
Mar 2024
-
-$8.97 M(+50.9%)
-$27.63 M(+7.6%)
Dec 2023
-
-$5.94 M(+9.0%)
-$25.69 M(-2.9%)
Sep 2023
-$26.46 M(-24.3%)
-$5.45 M(-25.0%)
-$26.46 M(-3.3%)
Jun 2023
-
-$7.27 M(+3.4%)
-$27.36 M(-5.1%)
Mar 2023
-
-$7.03 M(+4.7%)
-$28.83 M(-11.5%)
Dec 2022
-
-$6.71 M(+5.5%)
-$32.56 M(-6.7%)
Sep 2022
-$34.94 M(-4.8%)
-$6.36 M(-27.2%)
-$34.91 M(-5.9%)
Jun 2022
-
-$8.73 M(-18.8%)
-$37.08 M(+0.1%)
Mar 2022
-
-$10.76 M(+18.7%)
-$37.05 M(-5.6%)
Dec 2021
-
-$9.06 M(+6.3%)
-$39.24 M(+6.9%)
Sep 2021
-$36.71 M(+59.6%)
-$8.53 M(-2.1%)
-$36.71 M(+12.6%)
Jun 2021
-
-$8.71 M(-32.7%)
-$32.60 M(+14.0%)
Mar 2021
-
-$12.94 M(+98.0%)
-$28.60 M(+14.9%)
Dec 2020
-
-$6.54 M(+47.7%)
-$24.89 M(+8.2%)
Sep 2020
-$23.01 M(+89.9%)
-$4.42 M(-5.9%)
-$23.01 M(+5.6%)
Jun 2020
-
-$4.70 M(-49.1%)
-$21.78 M(+7.7%)
Mar 2020
-
-$9.23 M(+98.7%)
-$20.22 M(+42.1%)
Dec 2019
-
-$4.65 M(+45.4%)
-$14.23 M(+17.6%)
Sep 2019
-$12.12 M
-$3.20 M(+1.7%)
-$12.10 M(+10.4%)
Jun 2019
-
-$3.14 M(-3.2%)
-$10.97 M(+4.9%)
DateAnnualQuarterlyTTM
Mar 2019
-
-$3.25 M(+28.9%)
-$10.45 M(-7.9%)
Dec 2018
-
-$2.52 M(+22.3%)
-$11.34 M(+6.4%)
Sep 2018
-$10.66 M(+200.0%)
-$2.06 M(-21.5%)
-$10.66 M(+3.6%)
Jun 2018
-
-$2.62 M(-36.5%)
-$10.28 M(+178.4%)
Mar 2018
-
-$4.14 M(+125.4%)
-$3.69 M(-46.8%)
Dec 2017
-
-$1.84 M(+8.7%)
-$6.94 M(+95.3%)
Sep 2017
-$3.55 M(-70.4%)
-$1.69 M(-142.6%)
-$3.55 M(-40.7%)
Jun 2017
-
$3.97 M(-153.7%)
-$5.99 M(-56.4%)
Mar 2017
-
-$7.38 M(-575.9%)
-$13.75 M(+111.6%)
Dec 2016
-
$1.55 M(-137.6%)
-$6.50 M(-45.8%)
Sep 2016
-$11.98 M(+25.6%)
-$4.13 M(+8.8%)
-$11.98 M(+63.8%)
Jun 2016
-
-$3.80 M(+2928.8%)
-$7.32 M(-16.7%)
Mar 2016
-
-$125.30 K(-96.8%)
-$8.79 M(-27.9%)
Dec 2015
-
-$3.94 M(-832.4%)
-$12.18 M(+27.7%)
Sep 2015
-$9.54 M(+457.0%)
$537.30 K(-110.2%)
-$9.54 M(-9.2%)
Jun 2015
-
-$5.26 M(+49.6%)
-$10.51 M(+70.3%)
Mar 2015
-
-$3.52 M(+171.9%)
-$6.17 M(+122.2%)
Dec 2014
-
-$1.29 M(+199.2%)
-$2.78 M(+62.5%)
Sep 2014
-$1.71 M
-$432.60 K(-53.3%)
-$1.71 M(+33.9%)
Jun 2014
-
-$926.40 K(+645.3%)
-$1.28 M(+264.8%)
Mar 2014
-
-$124.30 K(-44.9%)
-$349.90 K(+55.1%)
Dec 2013
-
-$225.60 K
-$225.60 K

FAQ

  • What is ESSA Pharma annual EBITDA?
  • What is the all time high annual EBITDA for ESSA Pharma?
  • What is ESSA Pharma annual EBITDA year-on-year change?
  • What is ESSA Pharma quarterly EBITDA?
  • What is the all time high quarterly EBITDA for ESSA Pharma?
  • What is ESSA Pharma quarterly EBITDA year-on-year change?
  • What is ESSA Pharma TTM EBITDA?
  • What is the all time high TTM EBITDA for ESSA Pharma?
  • What is ESSA Pharma TTM EBITDA year-on-year change?

What is ESSA Pharma annual EBITDA?

The current annual EBITDA of EPIX is -$28.45 M

What is the all time high annual EBITDA for ESSA Pharma?

ESSA Pharma all-time high annual EBITDA is -$1.71 M

What is ESSA Pharma annual EBITDA year-on-year change?

Over the past year, EPIX annual EBITDA has changed by -$2.00 M (-7.55%)

What is ESSA Pharma quarterly EBITDA?

The current quarterly EBITDA of EPIX is -$6.33 M

What is the all time high quarterly EBITDA for ESSA Pharma?

ESSA Pharma all-time high quarterly EBITDA is $3.97 M

What is ESSA Pharma quarterly EBITDA year-on-year change?

Over the past year, EPIX quarterly EBITDA has changed by +$878.70 K (+12.19%)

What is ESSA Pharma TTM EBITDA?

The current TTM EBITDA of EPIX is -$28.45 M

What is the all time high TTM EBITDA for ESSA Pharma?

ESSA Pharma all-time high TTM EBITDA is -$225.60 K

What is ESSA Pharma TTM EBITDA year-on-year change?

Over the past year, EPIX TTM EBITDA has changed by -$879.30 K (-3.19%)